Trials / Completed
CompletedNCT00169897
Pulmonary Rehabilitation at Home Versus at the Gymnasium
Effects of a Home-based Versus a Hospital-based Outpatient Pulmonary Rehabilitation Program in Patients With COPD: a Multicenter, Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 252 (actual)
- Sponsor
- Laval University · Academic / Other
- Sex
- All
- Age
- 40 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
Short term efficacy of pulmonary rehabilitation for improving functional capacity and quality of life of chronic obstructive respiratory disease (COPD) patient is well known. However, there is an important gap between the scientific knowledge and the clinical use of pulmonary rehabilitation since a a very small number of patients benefit from this therapeutic intervention. We estimate that less than 1% of the 750 000 canadians suffering from COPD have access to a pulmonary rehabilitation program. We want to study the efficacy of a home-based rehabilitation program as a way to facilitate the access to rehabilitation.
Detailed description
This article on the main outcome is available. Maltais F, Bourbeau J, Shapiro S, Lacasse Y, Perrault H, Baltzan M, Hernandez P, Rouleau M, Julien M, Parenteau S, Paradis B, Levy RD, Camp P, Lecours R, Audet R, Hutton B, Penrod JR, Picard D, Bernard S. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Int Med 2008;149:869-878.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Pulmonary rehabilitation (teaching and exercise) | After a 4-week education program, patients took part to home-based rehabilitation or outpatient hospital-based rehabilitation for 8 weeks. Patients were subsequently followed for 40 weeks to complete the one-year study. |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2005-09-15
- Last updated
- 2010-11-15
Locations
10 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00169897. Inclusion in this directory is not an endorsement.